Evidence map›Paper›PMID 35701772›Full record

Observational studyBMC endocrine disorders2022

The prevalence and incidence of pharmacologically treated diabetes among older people receiving home care services in Norway 2009-2014: a nationwide longitudinal study.

Tonje Teigland, Jannicke Igland, Grethe S Tell, Johannes Haltbakk, Marit Graue, Anne-Siri Fismen, Kåre I Birkeland, Truls Østbye, Mark Peyrot, Marjolein M Iversen

Erratum issuedOpen access · goldAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in BMC endocrine disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Tonje TeiglandDepartment of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Norway. tote@hvl.no.
Jannicke IglandDepartment of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Norway.
Grethe S TellDepartment of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Johannes HaltbakkDepartment of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Norway.
Marit GraueDepartment of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Norway.
Anne-Siri FismenDepartment of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Norway.
Kåre I BirkelandInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Truls ØstbyeDepartment of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Mark PeyrotDepartment of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Norway.
Marjolein M IversenDepartment of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Norway. miv@hvl.no.
Western Norway University of Applied Sciences · NOUniversity of Bergen · NOUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA substantial proportion of older people who receive home care services (HCS) has diabetes and requires diabetes specific monitoring, treatment and self-care assistance. However, the prevalence and incidence rates of diabetes among older people in HCS are poorly described. The aim of the study is to estimate prevalence, incidence and time trends of pharmacologically treated diabetes among older people receiving HCS in Norway 2009-2014.

methodsThis nationwide observational cohort study is based on data from two population registries. The study population consisted of persons registered in the Norwegian Information System for the Nursing and Care Sector aged ≥ 65 years receiving HCS during at least one of the years 2009-2014. The Norwegian Prescription Database was utilized to identify participants' prescriptions for glucose lowering drugs (GLD). The period prevalence was calculated each year as persons with one or more prescriptions of GLD in the current or previous year. Incident cases were defined as subjects receiving prescriptions of GLD for the first time in the given calendar year if there were no prescriptions of any GLD for that person during the previous two years.

resultsFrom 2009 to 2014, the number of older people receiving HCS increased from 112,487 to 125,593. The proportion of these who received GLD increased from 14.2% to 15.7% (p < 0.001) and was significantly higher among men than women. The annual incidence rate of diabetes among those receiving HCS showed a decreasing trend from 95.4 to 87.5 cases per 10,000 person-years from 2011 to 2014, but when stratifying on age group and gender, was significant only among the oldest women (age groups 85-89 years and 90 +).

conclusionsThe increasing prevalence of older people with diabetes who receive HCS highlights the importance of attention to treatment and care related to diabetes in the HCS.

Indexed as

Diabetes MellitusHome Care ServicesAgedFemaleHumansIncidenceLongitudinal StudiesMaleNorwayPrevalenceHome care servicesIncidenceOlder peoplePharmacologically treated diabetesPrevalenceTime trends

Identifiers

PMID35701772
PMCPMC9195364
OpenAlexW4282823568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.